114 related articles for article (PubMed ID: 36707344)
1. Endometrial cancer of the very elderly: Management and survival in the Francogyn population.
Martin FA; Dion L; Nyangoh Timoh K; Dupré PF; Azaïs H; Bendifallah S; Touboul C; Dabi Y; Graesslin O; Raimond E; Costaz H; Kerbage Y; Huchon C; Mimoun C; Koskas M; Akladios C; Lecointre L; Canlorbe G; Chauvet P; Ouldamer L; Levêque J; Lavoué V
Eur J Surg Oncol; 2023 May; 49(5):1023-1030. PubMed ID: 36707344
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
Kuku S; Williams M; McCormack M
Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
[TBL] [Abstract][Full Text] [Related]
3. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
4. SATEN III-Splitting Adjuvant Treatment of stage III ENdometrial cancers: an international, multicenter study.
Kahramanoglu I; Meydanli MM; Taranenka S; Ayhan A; Salman C; Sanci M; Demirkiran F; Ortac F; Haidopoulos D; Sukhin V; Kaidarova D; Stepanyan A; Farazaneh F; Aliyev S; Ulrikh E; Kurdiani D; Yalcin İ; Mavrichev S; Akilli H; Sarı ME; Pletnev A; Aslan K; Bese T; Kairbayev M; Vlachos D; Gultekin M
Int J Gynecol Cancer; 2019 Oct; 29(8):1271-1279. PubMed ID: 31481453
[TBL] [Abstract][Full Text] [Related]
5. Survival outcomes and patterns of failure in women with stage IIIC
Lee JK; Mahan M; Hanna RK; Elshaikh MA
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():192-197. PubMed ID: 28800504
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Nodal Location and Ratio in Stage IIIC Endometrial Carcinoma Among a Multi-Institutional Academic Collaboration.
Mayadev J; Elshaikh MA; Christie A; Nagel C; Kennedy V; Khan N; Lea J; Ghanem A; Miller D; Xie XJ; Folkert M; Albuquerque K
Am J Clin Oncol; 2018 Dec; 41(12):1220-1224. PubMed ID: 29683799
[TBL] [Abstract][Full Text] [Related]
7. Postoperative Adjuvant Treatment in Women with Stage I Endometrial Cancer: A Retrospective Study.
Fu P; Sun H; Zhou T; Cui P; Wang S; Liu R
Int J Clin Pract; 2023; 2023():4007616. PubMed ID: 37035519
[TBL] [Abstract][Full Text] [Related]
8. Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group.
Reboux PA; Azaïs H; Canova CH; Bendifallah S; Ouldamer L; Raimond E; Hudry D; Coutant C; Graesslin O; Touboul C; Collinet P; Bricou A; Huchon C; Daraï E; Ballester M; Lévêque J; Lavoué V; Koskas M; Uzan C; Canlorbe G
J Gynecol Oncol; 2019 Jul; 30(4):e53. PubMed ID: 31074238
[TBL] [Abstract][Full Text] [Related]
9. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
10. Management and Survival of Elderly and Very Elderly Patients with Endometrial Cancer: An Age-Stratified Study of 1228 Women from the FRANCOGYN Group.
Poupon C; Bendifallah S; Ouldamer L; Canlorbe G; Raimond E; Hudry N; Coutant C; Graesslin O; Touboul C; Collinet P; Bricou A; Huchon C; Daraï E; Ballester M; Levêque J; Lavoue V
Ann Surg Oncol; 2017 Jun; 24(6):1667-1676. PubMed ID: 28008573
[TBL] [Abstract][Full Text] [Related]
11. Oncological Outcomes of Stage II Endometrial Cancer: A Retrospective Analysis of 250 Cases.
Ozgul N; Boyraz G; Salman MC; Gultekin M; Yuce K; Ibrahimov A; Erturk A; Gungorduk K; Gulseren V; Sanci M; Turkmen O; Karalok A; Kimyon G; Turan T; Ozkan NT; Meydanli MM; Gungor T; Ayik H; Simsek T
Int J Gynecol Cancer; 2018 Jan; 28(1):161-167. PubMed ID: 28930810
[TBL] [Abstract][Full Text] [Related]
12. Endometrial stromal sarcoma-A retropsective analysis of factors affecting recurrence.
Agarwal R; Rajanbabu A; Nair IR; Satish C; Jose G; Unikrishnan UG
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():92-97. PubMed ID: 28738297
[TBL] [Abstract][Full Text] [Related]
13. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
14. Clinical Outcomes of Surgically Unresectable Endometrial Cancers.
Conway JL; Lukovic J; Ferguson SE; Zhang J; Xu W; Dhani N; Croke J; Fyles A; Milosevic M; Rink A; Rouzbahman M; Han K
Am J Clin Oncol; 2019 Oct; 42(10):777-782. PubMed ID: 31503063
[TBL] [Abstract][Full Text] [Related]
15. Patterns of care and the survival of elderly patients with high-risk endometrial cancer: A case-control study from the FRANCOGYN group.
Rousselin A; Bendifallah S; Nyangoh Timoh K; Ouldamer L; Canlorbe G; Raimond E; Hudry N; Coutant C; Graesslin O; Touboul C; Collinet P; Bricou A; Huchon C; Daraï E; Ballester M; Levêque J; Lavoue V
Eur J Surg Oncol; 2017 Nov; 43(11):2135-2142. PubMed ID: 28888799
[TBL] [Abstract][Full Text] [Related]
16. Radiation, chemotherapy or combined modality therapy in adjuvant treatment for stage III endometrial carcinoma in lower southern Thailand: disease recurrence and overall survival.
Pichatechaiyoot A; Buhachat R; Boonyapipat S; Kanjanapradit K
J Med Assoc Thai; 2014 Mar; 97(3):274-82. PubMed ID: 25123006
[TBL] [Abstract][Full Text] [Related]
17. What Is the Optimal Adjuvant Treatment Sequence for Node-Positive Endometrial Cancer? Results of a National Cancer Database Analysis.
Modh A; Ghanem AI; Burmeister C; Hanna RK; Elshaikh MA
Int J Gynecol Cancer; 2018 Feb; 28(2):248-253. PubMed ID: 29240603
[TBL] [Abstract][Full Text] [Related]
18. Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group.
Meurer M; Floquet A; Ray-Coquard I; Bertucci F; Auriche M; Cordoba A; Piperno-Neumann S; Salas S; Delannes M; Chevalier T; Italiano A; Blay JY; Mancini J; Pautier P; Duffaud F
Int J Gynecol Cancer; 2019 May; 29(4):691-698. PubMed ID: 30772825
[TBL] [Abstract][Full Text] [Related]
19. Is there any benefit of paraaortic field irradiation in pelvic lymph node positive endometrial cancer patients? A propensity match analysis.
Onal C; Yuce Sari S; Akkus Yildirim B; Gultekin M; Guler OC; Yildiz F
J Obstet Gynaecol; 2020 Oct; 40(7):1012-1019. PubMed ID: 31793400
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value and Risk Factors of Peritoneal Carcinomatosis Recurrence for Patients with Endometrial Cancer: A Multicenter Study from the FRANCOGYN Group.
Gaudet Chardonnet A; Azaïs H; Ballester M; Raimond E; Bendifallah S; Ouldamer L; Coutant C; Graesslin O; Touboul C; Collinet P; Bricou A; Huchon C; Daraï E; Lavoue V; Koskas M; Uzan C; Canlorbe G
Ann Surg Oncol; 2021 Jan; 28(1):212-221. PubMed ID: 32648177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]